138 related articles for article (PubMed ID: 29955155)
1. The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.
Chang CC; Huang YS; Lin YM; Lin CJ; Jeng JC; Liu SM; Ho TL; Chang RT; Changou CA; Ho CC; Shih HM
Sci Rep; 2018 Jun; 8(1):9786. PubMed ID: 29955155
[TBL] [Abstract][Full Text] [Related]
2. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
3. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
5. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
6. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
7. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
8. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
10. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
11. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
13. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
14. SENP2 suppresses NF-κB activation and sensitizes breast cancer cells to doxorubicin.
Gao X; Wu Y; Qiao L; Feng X
Eur J Pharmacol; 2019 Jul; 854():179-186. PubMed ID: 30940449
[TBL] [Abstract][Full Text] [Related]
15. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
16. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
18. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
[TBL] [Abstract][Full Text] [Related]
19. SENP2 alleviates CCl
Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J
Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
